Ipilimumab/nivolumab/pembrolizumabEncephalitis: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1868卷 / 1期

关键词：

D O I：

10.1007/s40278-021-00684-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：227 / 227

相关论文

共 50 条

[1] Ipilimumab/nivolumab/pembrolizumabEncephalitis: 5 case reports
Reactions Weekly, 2019, 1784 (1) : 157 - 157
[2] Ipilimumab/nivolumab/pembrolizumabEncephalitis, radiculitis and meningitis: 7 case reports
Reactions Weekly, 2019, 1773 (1) : 206 - 206
[3] Ipilimumab/nivolumab/pembrolizumabMyocarditis: 4 case reports
Reactions Weekly, 2021, 1837 (1) : 367 - 367
[4] Ipilimumab/nivolumab/pembrolizumabPneumonitis: 4 case reports
Reactions Weekly, 2020, 1794 (1) : 131 - 131
[5] Ipilimumab/nivolumab/pembrolizumabThyroid disorders: 4 case reports
Reactions Weekly, 2022, 1902 (1) : 256 - 256
[6] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1685 (1) : 117 - 117
[7] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2020, 1792 (1) : 136 - 136
[8] Ipilimumab/nivolumab/pembrolizumabVarious toxicites: 4 case reports
Reactions Weekly, 2018, 1684 (1) : 141 - 141
[9] Ipilimumab/nivolumab/pembrolizumabVarious toxicities: 4 case reports
Reactions Weekly, 2018, 1705 (1) : 176 - 176
[10] Ipilimumab/nivolumab/pembrolizumabVarious toxicities : 4 case reports
Reactions Weekly, 2021, 1886 (1) : 239 - 239

← 1 2 3 4 5 →